These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1978329)

  • 1. Correlation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its function.
    Brandt-Rauf PW; Rackovsky S; Pincus MR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8660-4. PubMed ID: 1978329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein.
    Brandt-Rauf PW; Pincus MR; Chen JM
    J Protein Chem; 1989 Dec; 8(6):749-56. PubMed ID: 2576207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states.
    Brandt-Rauf PW; Pincus MR; Monaco R
    J Protein Chem; 1995 Jan; 14(1):33-40. PubMed ID: 7779261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation of the transmembrane domain of the epidermal growth factor receptor.
    Brandt-Rauf PW; Monaco R; Pincus MR
    J Protein Chem; 1994 Feb; 13(2):227-31. PubMed ID: 7914727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.
    Bargmann CI; Weinberg RA
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5394-8. PubMed ID: 2899890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of a mutation in the transmembrane domain of the p185c-erbB2 oncogene-encoded protein studied by molecular dynamics simulations.
    Garnier N; Genest D; Hebert E; Genest M
    J Biomol Struct Dyn; 1994 Apr; 11(5):983-1002. PubMed ID: 7946067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
    Stern DF; Heffernan PA; Weinberg RA
    Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.
    Guy PM; Carraway KL; Cerione RA
    J Biol Chem; 1992 Jul; 267(20):13851-6. PubMed ID: 1352772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.
    Bargmann CI; Hung MC; Weinberg RA
    Cell; 1986 Jun; 45(5):649-57. PubMed ID: 2871941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.
    Stern DF; Kamps MP; Cao H
    Mol Cell Biol; 1988 Sep; 8(9):3969-73. PubMed ID: 2464744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An extra cysteine proximal to the transmembrane domain induces differential cross-linking of p185neu and p185neu.
    Cao H; Bangalore L; Dompé C; Bormann BJ; Stern DF
    J Biol Chem; 1992 Oct; 267(28):20489-92. PubMed ID: 1356980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subdomain in the transmembrane domain is necessary for p185neu* activation.
    Cao H; Bangalore L; Bormann BJ; Stern DF
    EMBO J; 1992 Mar; 11(3):923-32. PubMed ID: 1347745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neu and its ligands: from an oncogene to neural factors.
    Peles E; Yarden Y
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.
    Chen LI; Webster MK; Meyer AN; Donoghue DJ
    J Cell Biol; 1997 May; 137(3):619-31. PubMed ID: 9151669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of neu-induced clonogenicity by dimethylsulfoxide correlates with decreased levels of neu-encoded cell-surface p185 and changes in phosphotyrosine content of endogenous proteins.
    Matin A; Hung MC
    Cancer Lett; 1993 Jan; 68(1):55-60. PubMed ID: 7678546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS
    Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. neu protooncogene fused to an immunoglobulin heavy chain gene requires immunoglobulin light chain for cell surface expression and oncogenic transformation.
    Flanagan JG; Leder P
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8057-61. PubMed ID: 2903500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo.
    Lofts FJ; Hurst HC; Sternberg MJ; Gullick WJ
    Oncogene; 1993 Oct; 8(10):2813-20. PubMed ID: 8104327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro.
    Cao H; Decker S; Stern DF
    Oncogene; 1991 May; 6(5):705-11. PubMed ID: 1675782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.